acetylcysteine has been researched along with Eye Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hernández-Martın, A; Malhotra, R; Oji, V | 1 |
Amano, S; Inagaki, Y; Inoue, H; Okamoto, T; Takeuchi, M; Yamagishi, S | 1 |
Horikiri, Y; Matsuyama, T; Morita, T; Yamahara, H; Yoshino, H | 1 |
Chermet, M; Haut, J; Labrune, P; Ullern, M | 1 |
Wright, P | 1 |
1 review(s) available for acetylcysteine and Eye Disorders
Article | Year |
---|---|
Ocular manifestations, complications and management of congenital ichthyoses: a new look.
Topics: Acetylcysteine; Eye Diseases; Eyelids; Humans; Ichthyosis; Lubricant Eye Drops; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Retinoids; Skin Transplantation | 2018 |
1 trial(s) available for acetylcysteine and Eye Disorders
Article | Year |
---|---|
[New trial treatment of dry eye with acetylcysteine ophthalmic solution].
Topics: Acetylcysteine; Clinical Trials as Topic; Corneal Ulcer; Drug Evaluation; Eye Diseases; Humans; Keratoconjunctivitis; Ophthalmic Solutions; Tears | 1977 |
3 other study(ies) available for acetylcysteine and Eye Disorders
Article | Year |
---|---|
Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Cattle; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Eye Diseases; Eye Proteins; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; Leptin; Microcirculation; Neovascularization, Pathologic; Nerve Growth Factors; Proteins; Reactive Oxygen Species; Receptors, Leptin; Receptors, Vascular Endothelial Growth Factor; Retinal Neovascularization; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serpins; Thymidine; Time Factors; Vascular Endothelial Growth Factor A | 2003 |
Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.
Topics: Absorption; Acetylcysteine; Administration, Inhalation; Animals; Area Under Curve; Biological Availability; Calcitonin; Cellulose; Chemistry, Pharmaceutical; Data Interpretation, Statistical; Dogs; Expectorants; Eye Diseases; Irritants; Male; Nasal Mucosa; Powders; Rabbits; Rats; Rats, Wistar | 2006 |
The dry eye.
Topics: Acetylcysteine; Anti-Bacterial Agents; Blepharitis; Conjunctivitis; Cornea; Epithelium; Expectorants; Eye Diseases; Folliculitis; Humans; Keratoconjunctivitis; Lacrimal Apparatus; Mucus; Tears; Time Factors | 1975 |